Novel eye therapeutics to help combat blindness

The EU-funded 3D-NET project has created a novel European industry-academia network to exchange knowledge, people and expertise between partners as a means to enhance the discovery and development of drugs that target blindness.

Focusing on the training and up-scaling of a grand total of 27 younger Marie-Currie Fellowship researchers, the 3D-NET (Drug Discovery and Development for Novel Eye Therapeutics) project also had the distinct research objective to discover and further develop drugs that target ocular pathologies, in particular retinal vascular permeability, unwanted blood vessel growth, inflammation and cell degeneration.

Further details: Novel eye therapeutics to help combat blindness